Friday 27 May 2016

  • Young Investigator Award Session
    08:30-08:35 Introduction
    08:35-08:50 Paracetamol-protein adducts following acute paracetamol overdose (abstract no. 237)
    Lecturer: Angela Chiew, Prince of Wales Hospital, Sydney, Australia
    08:50-09:05 Analytical confirmation of the synthetic cannabinoid receptor agonists (SCRAs) present in a cohort of presentations with acute recreational drug toxicity to an Emergency Department (ED) in London, UK (abstract no. 238)
    Lecturer: Rachelle Abouchedid, Guy's and St Thomas' NHS Foundation Trust, London, UK
    09:05-09:20 Hepatotoxicity of novel psychoactive substances structurally related to 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine (abstract no. 239)
    Lecturer: Dino Luethi, University of Basel, Basel, Switzerland
    09:20-09:35 In vitro pharmacological profiles of classical psychedelics and novel synthetic hallucino-genic substances and their relevance for clinical toxicology (abstract no. 240)
    Lecturer: Anna Rickli, University of Basel, Basel, Switzerland
    09:35   Judging commences
    09:35-09:55 Data base: List and text of all presentation of the EAPCC(T) Congresses 1964-2015
    CME accreditation will not be requested for this lecture
    Lecturer: Thomas Zilker, Munich, Germany
    09:55-10:00 Presentation to the winner of the YIA

    Risk communication - Detection, assessment, management and communication of risk in mass human toxic exposures
    10:00-10:45 Coffee and electronic posters
    E-POSTERS from 242 to 248 and from 250 to 252 (see detailed at E-Posters tab)
    10:45-11:05 Chemical warfare scenarios
    Lecturer: Jose Luis Lopez-Colon, Ministry of Defence, Madrid, Spain
    11:05-11:25 Detection and minimizing risk in outbreaks by contaminated beverages. The methanol experience
    Lecturer: Hossein Hassanian-Moghaddam, Shahid Beheshti University of Medical Sciences, Tehran, Iran
    11:25-11:45 Risk communication in lead poisoning outbreaks in Nigeria - lessons learnt and suggestions for the future
    Lecturer: Natalie Thurtle, St George Hospital, Sydney, Australia
    11:45-12:05 Environmental contamination by organochlorinated residues: Lindane manufacture residues
    Lecturer: Ana Ferrer Dufol, Clinic University Hospital, Zaragoza, Spain
    12:05-12:25 Risk communication in mass poisoning situations
    Lecturer: Charles McKay, Vice President, ACMT, Malborough, USA
    12:25-12:30 General discussion
    12:30-14:15 Lunch and posters

    Plenary lecture followed by Advances in critical care of poisoned patients: imaging and treatment
    14:15-15:00 Lipid rescue to treat acute poisonings: the fundamentals and the future
    Lecturer: Guy Weinberg, University of Illinois and Jesse Brown VA, Chicago, USA
    15:00-15:20 Lipid emulsions in clinical toxicology: appraisal of the evidence
    Lecturer: Sophie Gosselin, Mc Gill University Health Center, Montréal, Canada
    15:20-15:25 General discussion
    15:25-15:45 MRI investigation of the central nervous system (CNS) following different etiologies of poisoning
    Lecturer: Philippe Hantson, Université catholique de Louvain, Brussels, Belgium
    15:45-16:15 Coffee and electronic posters
    E-POSTERS from 253 to 260 (see detailed at E-Posters tab)
    16:15-16:35 Poisoned patients as potential organ donors. The Spanish experience
    Lecturer: Beatriz Mahíllo Durán, Spanish National Transplant Organization, Madrid, Spain
    16:35-17:20 Debate: Sedation of agitated poisoned patient - is dexmedetomidine a reasonable first-line to propose?
    Dylan de Lange (PRO), University Medical Center, Utrecht, The Netherlands
    Geoff Isbister (CON), University of Newcastle, Newcastle, Australia
  • Aerotoxic syndrome
    10:45-11:05 Aerotoxic Syndrome - Historical, technical und toxicological background
    Lecturer: Axel Hahn, Federal Institute of Risk Assessment, Berlin, Germany
    11:05-11:25 Reported cabin fume events: What did the investigations show?
    Lecturer: Michael Bagshaw, Kings College London, London, UK
    11:25-11:45 Is there a toxicological explanation for features following cabin fume events?
    Lecturer: J Allister Vale, NPIS (Birmingham Unit), City Hospital, Birmingham, UK
    11:45-12:05 Bioanalytical methods for monitoring of tricresylphosphate exposure (TCP)
    Lecturer: Harald John, Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany
    12:05-12:25 Investigating and diagnosing patients who have been exposed to cabin fume events
    Lecturer: Nina Glaser, Federal Institute for Risk Assessment, Berlin, Germany
    12:25-12:30 General discussion
    12:30-14:15 Lunch and posters

    Risk communication - Detection, assessment, management and communication of risk in mass human toxic exposures (continued) followed by Poster discussion session
    15:00-15:45 Benefits and drawbacks of strict regulation on chemicals (US, EU versus developing countries regulations) / two faces of the same coin
    Michael Eddleston, University of Edinburgh, Edinburgh, UK
    Peter Smith, European Chemistry Industry Council (Cefic), Brussels,  Belgium
    15:45-16:15 Coffee and electronic posters
    E-POSTERS from 253 to 260 (see detailed at E-Posters tab)
    16:15-16:35 Municipal Water Contamination By Perfluoroalkyl Substances: Lessons Learned
    Alan Woolf, Boston Children's Hospital, Boston, USA
    Karen Simone, Northern New England Poison Center, Portland, USA
    16:35-16:50 Rapid triage of victims of suspected chemical attack using a one questionnaire for identification of the toxidrome: The experience of Médecins Sans Frontières (MSF) (abstract no. 261)
    Lecturer: Frederic Baud, Doctors without Borders, Paris, France
    16:50-17:20 Poster discussion session
    CME accreditation will not be requested for this session

    • 262. Aerotoxic syndrome: Aircraft involved in contaminated cockpit/cabin air exposure and related symptoms in 11 patients referred for review in a specialist clinical toxicology outpatient service 
    • 263. A characterization of occupational irritant and asphyxiant gas exposures 
    • 264. Ethanol strips for bedside monitoring of ethanol concentrations during treatment of toxic alcohols: Preliminary results 
    • 265. Routine toxicological analysis does not meet clinical needs: An endless breakdown in spite of modern technology
    • 266. The evidence for acute tolerance to human alcohol intoxication (the Mellanby effect): A systematic review 
    • 267. Occupational transdermal poisoning with synthetic cannabinoids
    • 268. Carbon monoxide poisoning in wood pellet storerooms  
    • 269. Pesticide exposure among professional users